LRP2 and early-onset autosomal dominant Alzheimer disease: As an endocytic receptor for multiple ligands, megalin also actively participates in amyloid-β (Aβ) clearance [54], and a recent study showed that blood-brain barrier megalin-knockout mice model developed neurodegeneration and Alzheimer's disease-like symptoms [55].